Sichuan Kelun Pharmaceutical Co., Ltd. (002422.SZ)
CNY 30.51
(-0.46%)
CNY 30.51
(-0.46%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 36.52 Billion CNY | 7.05% |
| 2022 | 34.11 Billion CNY | 8.18% |
| 2021 | 31.53 Billion CNY | -1.39% |
| 2020 | 31.98 Billion CNY | 1.58% |
| 2019 | 31.48 Billion CNY | 7.24% |
| 2018 | 29.36 Billion CNY | 4.9% |
| 2017 | 27.98 Billion CNY | 19.56% |
| 2016 | 23.4 Billion CNY | 3.66% |
| 2015 | 22.58 Billion CNY | 6.51% |
| 2014 | 21.2 Billion CNY | 18.14% |
| 2013 | 17.94 Billion CNY | 20.2% |
| 2012 | 14.93 Billion CNY | 42.67% |
| 2011 | 10.46 Billion CNY | 19.06% |
| 2010 | 8.78 Billion CNY | 163.69% |
| 2009 | 3.33 Billion CNY | 25.5% |
| 2008 | 2.65 Billion CNY | 48.62% |
| 2007 | 1.78 Billion CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 37.67 Billion CNY | 3.15% |
| 2024 Q2 | 38.04 Billion CNY | 0.97% |
| 2024 Q3 | 38.39 Billion CNY | 0.92% |
| 2023 Q4 | 36.52 Billion CNY | 1.57% |
| 2023 Q1 | 36.1 Billion CNY | 5.82% |
| 2023 FY | 36.52 Billion CNY | 7.05% |
| 2023 Q2 | 34.9 Billion CNY | -3.33% |
| 2023 Q3 | 35.95 Billion CNY | 3.03% |
| 2022 FY | 34.11 Billion CNY | 8.18% |
| 2022 Q4 | 34.11 Billion CNY | 1.87% |
| 2022 Q3 | 33.49 Billion CNY | 2.84% |
| 2022 Q2 | 32.56 Billion CNY | -4.11% |
| 2022 Q1 | 33.96 Billion CNY | 7.69% |
| 2021 Q1 | 31.74 Billion CNY | -0.74% |
| 2021 Q3 | 31.84 Billion CNY | -0.59% |
| 2021 Q4 | 31.53 Billion CNY | -0.95% |
| 2021 Q2 | 32.03 Billion CNY | 0.9% |
| 2021 FY | 31.53 Billion CNY | -1.39% |
| 2020 Q2 | 30.89 Billion CNY | -5.15% |
| 2020 Q4 | 31.98 Billion CNY | -0.18% |
| 2020 FY | 31.98 Billion CNY | 1.58% |
| 2020 Q3 | 32.04 Billion CNY | 3.7% |
| 2020 Q1 | 32.57 Billion CNY | 3.46% |
| 2019 Q2 | 30.26 Billion CNY | 1.51% |
| 2019 FY | 31.48 Billion CNY | 7.24% |
| 2019 Q1 | 29.81 Billion CNY | 1.54% |
| 2019 Q4 | 31.48 Billion CNY | 5.31% |
| 2019 Q3 | 29.89 Billion CNY | -1.21% |
| 2018 Q3 | 29.06 Billion CNY | 2.87% |
| 2018 Q4 | 29.36 Billion CNY | 1.02% |
| 2018 Q1 | 28.63 Billion CNY | 2.31% |
| 2018 Q2 | 28.25 Billion CNY | -1.33% |
| 2018 FY | 29.36 Billion CNY | 4.9% |
| 2017 Q2 | 24.85 Billion CNY | -2.86% |
| 2017 FY | 27.98 Billion CNY | 19.56% |
| 2017 Q4 | 27.98 Billion CNY | 3.58% |
| 2017 Q3 | 27.01 Billion CNY | 8.71% |
| 2017 Q1 | 25.58 Billion CNY | 9.29% |
| 2016 Q3 | 23.79 Billion CNY | -0.24% |
| 2016 Q4 | 23.4 Billion CNY | -1.63% |
| 2016 Q2 | 23.85 Billion CNY | 0.92% |
| 2016 FY | 23.4 Billion CNY | 3.66% |
| 2016 Q1 | 23.63 Billion CNY | 4.67% |
| 2015 Q1 | 21.54 Billion CNY | 1.6% |
| 2015 FY | 22.58 Billion CNY | 6.51% |
| 2015 Q3 | 22.24 Billion CNY | 3.11% |
| 2015 Q4 | 22.58 Billion CNY | 1.54% |
| 2015 Q2 | 21.57 Billion CNY | 0.14% |
| 2014 Q4 | 21.2 Billion CNY | 3.73% |
| 2014 Q3 | 20.44 Billion CNY | 6.79% |
| 2014 Q2 | 19.14 Billion CNY | 4.68% |
| 2014 FY | 21.2 Billion CNY | 18.14% |
| 2014 Q1 | 18.28 Billion CNY | 1.88% |
| 2013 FY | 17.94 Billion CNY | 20.2% |
| 2013 Q4 | 17.94 Billion CNY | -1.45% |
| 2013 Q3 | 18.21 Billion CNY | 10.28% |
| 2013 Q2 | 16.51 Billion CNY | -0.8% |
| 2013 Q1 | 16.64 Billion CNY | 11.49% |
| 2012 FY | 14.93 Billion CNY | 42.67% |
| 2012 Q1 | 10.78 Billion CNY | 3.04% |
| 2012 Q2 | 13.74 Billion CNY | 27.45% |
| 2012 Q3 | 13.62 Billion CNY | -0.84% |
| 2012 Q4 | 14.93 Billion CNY | 9.57% |
| 2011 Q1 | 9.16 Billion CNY | 4.23% |
| 2011 FY | 10.46 Billion CNY | 19.06% |
| 2011 Q3 | 10.03 Billion CNY | 5.73% |
| 2011 Q4 | 10.46 Billion CNY | 4.26% |
| 2011 Q2 | 9.49 Billion CNY | 3.62% |
| 2010 Q2 | 8.15 Billion CNY | 140.28% |
| 2010 Q1 | 3.39 Billion CNY | 1.79% |
| 2010 Q3 | 8.29 Billion CNY | 1.72% |
| 2010 Q4 | 8.78 Billion CNY | 6.0% |
| 2010 FY | 8.78 Billion CNY | 163.69% |
| 2009 FY | 3.33 Billion CNY | 25.5% |
| 2009 Q4 | 3.33 Billion CNY | 0.0% |
| 2008 FY | 2.65 Billion CNY | 48.62% |
| 2007 FY | 1.78 Billion CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 13.9 Billion CNY | -162.6% |
| Zhejiang Zhenyuan Share Co., Ltd. | 2.98 Billion CNY | -1123.936% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 1.06 Billion CNY | -3344.591% |
| Hubei Guangji Pharmaceutical Co., Ltd. | 3.02 Billion CNY | -1105.624% |
| Yifan Pharmaceutical Co., Ltd. | 11.49 Billion CNY | -217.617% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 847.56 Million CNY | -4209.366% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 2.89 Billion CNY | -1163.442% |
| Boai NKY Medical Holdings Ltd. | 4.01 Billion CNY | -808.642% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 2.56 Billion CNY | -1325.536% |